Physicians' Academy for Cardiovascular Education

Consuming probiotics can reduce blood pressure

Khalesi S et al., Hypertension. 2014 - Hypertension. 2014 Jul 21


Effect of Probiotics on Blood Pressure : A Systematic Review and Meta-Analysis of Randomized, Controlled Trials

Khalesi S, Sun J, Buys N et al.
Hypertension. 2014 Jul 21. pii: HYPERTENSIONAHA.114.03469. [Epub ahead of print]


Blood pressure (BP) can be controlled through diet and lifestyle modification. Not only are low-fat diets rich in fruits and vegetables and low in sodium suggested to lower BP [1-3], dietary constituents and supplements such as omega-3 fatty acids [4], garlic [5], and green tea [6,7] have also been found to improve BP control.
Probiotics have been studied for possible health benefits in improving immune system function [8] and preventing diarrhea [9,10]. These live microorganisms, when consumed in adequate amounts, may also improve BP through mechanisms including improving total cholesterol and LDL-c [11-13], reducing blood glucose levels and insulin resistance [14,15] and regulating the renin-angiotensin system [16,17].
Effects of probiotic consumption on BP have yielded inconclusive results. Therefore, a systematic review and meta-analysis of randomised controlled trials was conducted, on 9 eligible trials, with 543 participants. 7 studies reported a double-blind design, and one a single-blind design, and one did not report the blinding process. The probiotic source, species and dose used varied between studies, with total daily dose of probiotic consumption ranging from 109 colony-forming units (CFU) to 1012 CFU. Study duration varied from three weeks to nine weeks.

Main results

  • 8 out of 9 studies reported a reduction in SBP after consuming probiotics, with a mean reduction ranging from 1.07 mmHg to 14.10 mmHg, of which 5 studies that reported a clinically significant reduction of SBP>5 mmHg.
  • The meta-analysis of 9 studies revealed a significant reduction of SBP by 3.56 mmHg (95%CI: -6.46 to -0.66, P<0.01) after probiotics consumption, as compared to the control group. Statistical heterogeneity was high among studies (I2=89%, P<0.05).
  • All 8 out of 9 studies that presented changes in DBP, reported a reduction after probiotics consumption (ranging from -0.9 to -8 mmHg), albeit only statistically significant in two studies.
  • The meta-analysis of 8 studies yielded a significant change of -2.38 mmHg (95%CI: -3.84 to -0.93, P<0.01) in mean difference of DBP as compared with control groups (I2=78%, P<0.05).
  • No meaningful relationship was found between the daily dose of probiotics consumed and reduction in SBP or DBP, although a subgroup analysis of studies with a daily dose of >1011 CFU showed a significant reduction in SBP and DBP, whereas studies with a daily dose of <1011CFU did not.


These results show that consumption of probiotics can significantly reduce SBP by 3.56 mmHg and DBP by 2.38 mmHg, which is similar to a recently reported effect of reducing salt intake by <2 g per day. This reduction is modest, but even a small reduction of BP may have relevant public health benefits and cardiovascular consequences. Therefore, probiotics may be used as a potential supplement to help prevent hypertension or improve BP control. Further studies may clarify the specific effects of different products, species and doses.
Find this article on Pubmed


1. Whelton SP, Hyre AD, Pedersen B, et al. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. J Hypertens. 2005;23:475–481.
2. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens. 2002;16:761–770.
3. Appel LJ, Brands MW, Daniels SR, et al; American Heart Association. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296–308.
4. Colussi G, Catena C, Dialti V, et al. Fish meal supplementation and ambulatory blood pressure in patients with hypertension: relevance of baseline membrane fatty acid composition. Am J Hypertens. 2014;27:471–481.
5. Reinhart KM, Coleman CI, Teevan C, et al. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother. 2008;42:1766–1771.
6. Basu A, Du M, Sanchez K, et al. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition. 2011;27:206–213.
7. Hartley L, Flowers N, Holmes J, et al. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;6:CD009934.
8. Moro-García MA, Alonso-Arias R, Baltadjieva M, et al. Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects. Age (Dordr). 2013;35:1311–1326.
9. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101:812–822.
10. Szajewska H, Skórka A, Ruszczyński M, et al. Metaanalysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther. 2007;25:871–881.
11. Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol. 2006;72:1729–1738.
12. Patel AK, Singhania RR, Pandey A, et al. Probiotic bile salt hydrolase: current developments and perspectives. Appl Biochem Biotechnol. 2010;162:166–180.
13. Guo Z, Liu XM, Zhang QX, S et al. Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 2011;21:844–850.
14. Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 2003;37:343–350.
15. Tabuchi M, Ozaki M, Tamura A, et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem. 2003;67:1421–1424.
16. Ong L, Shah NP. Release and identification of angiotensin-converting enzyme-inhibitory peptides as influenced by ripening temperatures and probiotic adjuncts in Cheddar cheeses. LWT-Food Sci Technol. 2008;41:1555–1566.
17. Seppo L, Jauhiainen T, Poussa T et al. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive ssubjects. Am J Clin Nutr. 2003;77:326–330.